Create possibilities for life

With the power of science and technology, guard every heartbeat

Start with the end of heart failure

Create an innovative medical device platform for cardiovascular full cycle solutions

Innovation starts with demand

We are committed to providing more optimized products and treatment programs for doctors and patients around the world

Weike Medical

Vickor Medical

Innovative in the cardiovascular field

medical device enterprises

Heart Failure Devices | Structural Heart Disease | Cardiac Stroke Prevention

Explore More →

Wuhan Vickor Medical Technology Co., Ltd. was established in July 2018, focusing on major clinical needs in the cardiovascular field, especially in the field of minimally invasive intervention for heart failure and structural heart disease. It is committed to creating an innovative medical device platform for cardiovascular full-cycle solutions through research and development, technical services, production and sales, and providing more optimized products and treatment plans for global doctors and patients.

The company is headquartered in Wuhan East Lake High-tech Zone, and in Suzhou, Beijing, Shanghai and other places of the layout of the industrial chain upstream and downstream. The founder and scientific research team of the company are composed of structural heart disease intervention experts, cardiac surgery experts, metal materials experts, weaving device research and development experts, and medical device registration experts, forming a strong combination of medical research and enterprise.

The company's products cover a variety of areas, including atrial shunts related to heart failure prevention, patent foramen ovale occluders related to cardiac stroke prevention, transcatheter aortic valve replacement systems related to valve disease treatment, and related surgical accessories consumables. The company has applied for more than 60 patents, including more than 50 invention patents, 10 utility model patents, and 3 PCT patents. Related products have complete independent core intellectual property rights. Atrial shunts were approved by the NMPA "Special Review Procedure for Innovative Medical Devices" and FDA "Breakthrough Medical Device Designation".

Innovation is rooted in the heart. In the future, Vickor Medical will continue to deepen the field of heart failure and structural heart disease, guided by the needs of global doctors and patients, and contribute more innovative forces to the cause of human health.